Updated: June 13, 2026
About the program
Program type
Investment focus areas
Therapy
Consumer Packaged Goods
Bioimaging
Molecules
Drugs
Metabolites
Genomics
Med Device
Therapeutics
In Vitro Diagnostics
Cosmetics
Proteomics
IVD
Biomarker
Pharmaceuticals
Mrna
Medicine
Cytometry
Clothing
Metabolomics
Pharma
Therapeutic
Fast Moving Consumer Goods
Fashion
Diagnostics
Gene
Gene Therapy
Retail Goods
Sequencing
Medical Device
Drug
Celle Therapy
Transcriptomics
Beauty
Medical Devices
CPG
Brands
Health
Clothes
Protein
Life Sciences Tools
Omics
MedTech
DNA
FMCG
Consumer Goods
PCR
CGT
Spectrometry
Goods
Food
Reagent
Nutrition
Description
A US-focused seed stage fund for gene tech (DNA, RNA, proteins, cells)
Location
Countries invested
Headquarters1018 Alma St, Menlo Park, CA 94025
Program details
Value add
We help founders by working creatively to provide things that they ask for and otherwise staying out of their way. We move quickly and don't waste founders' time.
Investment offer
Check size$50,000,000 – $500,000
Can lead rounds
No
Lead preference
Never
Funding requirements
We invest in US-incorporated gene tech seed stage startups applying or enabling genomics and synbio to health and happiness (therapeutics, diagnostics, vaccines, cosmetics) and other industries (food/ag, veterinary, materials/chemicals). In general, we want to connect with startups working with DNA, RNA, proteins, and -omics.